Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics. Read more about Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics.
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Read more about Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Read more about A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
Virtual Colonoscopy Using Omnipaque as a Contrast Agent Read more about Virtual Colonoscopy Using Omnipaque as a Contrast Agent
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies Read more about Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? Read more about Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment Read more about Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
Corrona Inflammatory Bowel Disease (IBD) Registry Read more about Corrona Inflammatory Bowel Disease (IBD) Registry
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer Read more about Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin Read more about Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin